Background. We test the hypotheses that use of the Chest Pain Choice (CPC) decision aid (DA) would be similarly effective in potentially vulnerable subgroups but increase knowledge more in patients with higher education and trust in physicians more in patients from racial minority groups. Methods. This was a secondary analysis of a multicenter randomized trial in adults with chest pain potentially due to acute coronary syndrome. The trial compared an intervention group engaged in shared decision making (SDM) using CPC to a control group receiving usual care (UC). We assessed for subgroup effects based on age, sex, race, income, insurance, education, literacy, and numeracy. We dichotomized each characteristic and tested for interactions using regression models with indicators for arm assignment and study site. Results. Of 898 patients (451 DA, 447 UC), over 50% were female, over one-third were black, nearly one-third had a high school education or less, and over 60% had ''low'' health literacy. The DA did not increase knowledge more in patients with higher education (P for interaction = 0.06) but did increase knowledge more in the ''typical'' than in the ''low'' numeracy subgroup (10.6% v. 4.7%, absolute difference [AD] = 5.9%, P for interaction = 0.025). The DA did not significantly increase patient trust in physicians in racial minorities (P for interaction = 0.06) but did increase trust more in patients with ''low'' literacy compared with those with ''typical'' literacy (3.7% v. -1.4%, AD = 5.1, P for interaction = 0.011). Conclusions. CPC benefited all sociodemographic groups to a similar extent, with greater knowledge transfer in patients with higher numeracy and greater physician trust in patients with ''low'' health literacy. Tailoring SDM interventions to patient characteristics may be necessary for optimal effectiveness. High value health care requires the delivery of effective care in a patient-centered and equitable manner. The National Academy of Medicine proposed shared decision making (SDM) as one of 10 essential elements of a highvalue health care system. Interventions, such as decision aids (DAs) to promote SDM, can improve patients' knowledge about their options, communicate risk
High value health care requires the delivery of effective care in a patient-centered and equitable manner. The National Academy of Medicine proposed shared decision making (SDM) as one of 10 essential elements of a highvalue health care system. Interventions, such as decision aids (DAs) to promote SDM, can improve patients' knowledge about their options, communicate risk accurately, and enhance patient engagement in decision making. 1, 2 Whether SDM interventions prevent or mitigate health disparities is unclear.
Few studies have specifically addressed the effects of SDM interventions in potentially vulnerable populations. Data from qualitative investigations suggest that patients from racial and ethnic minority groups are more likely to experience barriers to communicating with their physicians 3 and report less interest in SDM than other groups of patients. 4, 5 In a patient-level meta-analysis of 7 randomized trials assessing the efficacy of patient DAs used during the clinical encounter, 2 we observed efficacy estimates similar to the trial population when DAs were used with potentially vulnerable patients such as the elderly and those with less income and less formal education. We also observed, however, a greater increase in knowledge of risk among patients with higher education compared with those with less education. Subgroup effects based on race yielded imprecise results.
A recently completed multicenter randomized trial testing the effectiveness of a DA, Chest Pain Choice (CPC), in 898 patients across 6 geographically diverse emergency departments (EDs) across the United States offers a new opportunity to evaluate SDM effects in potentially vulnerable populations. 6 This trial alone offered more participants and greater racial and socioeconomic diversity than all trials combined in the metaanalysis. 2 Based on the findings of the meta-analysis, we hypothesized that use of CPC would increase knowledge, decrease decisional conflict, and increase patient engagement across all sociodemographic patient groups but would also increase knowledge to a relatively greater degree in patients with higher levels of education, health literacy, and numeracy. Moreover, given empiric data demonstrating high levels of patient trust in physicians in a cohort consisting largely of Caucasian patients 7 and less positive perceptions of clinicians in patients from racial minority groups, 8 we hypothesized that use of CPC would increase patient trust in physicians to a greater degree in patients from racial minority groups.
Methods

Study Design
This is a secondary analysis of data from a trial for which the background and methods have been described previously. 9 Briefly, the trial was a pragmatic parallel 2-arm randomized controlled trial conducted in 6 EDs across the United States (Mayo Clinic, Rochester; Mayo Clinic, Jacksonville; Indiana University; University of California, Davis; University of Pennsylvania; and Thomas Jefferson University) with patients presenting with chest pain potentially due to acute coronary syndrome (ACS). The intervention group was engaged in risk communication and SDM regarding whether to be admitted for observation and receive further testing or to be discharged with outpatient follow-up using CPC. The control group received usual care (UC).
Participants
Eligible patients included adults (.17 years of age) who presented to the ED with a chief complaint of chest pain, had a negative initial cardiac workup (including no ischemic electrocardiogram [ECG] changes and an initial cardiac troponin below the upper limit of normal), and were being considered for placement in an observation unit for further cardiac workup (coronary computed tomography [CT] angiography or stress testing). Patients with a history of coronary artery disease, a plan for cardiac intervention or admission, cocaine use in the past 72 hours, or barriers to outpatient follow-up; prisoners; pregnant women; and those who were hearing or visually impaired or otherwise unable to use the DA were excluded. Institutional review board approval was obtained at each of the participating hospitals.
Study Treatments
Intervention. CPC was developed by the research team through an iterative process that involved a participatory action research methodology 10 and extensive field testing and can be accessed at http://shareddecisions.mayoclinic.org/decision-aid-information/chest-pain-choice-decis ion-aid/. Field testing was performed with patients in the ED, with over one-fourth of the population reporting an education level of high school or less. This development process has been described. 9, 11 For each patient enrolled in the intervention arm, a study coordinator selected the DA that corresponded to each patient's level of risk (calculated using a quantitative pretest probability instrument 12 using patient-specific variables) and provided the DA to the clinician. Once the initial ED evaluation was complete and the clinician was ready to make a patient disposition, the clinician used the DA to facilitate a SDM discussion with the patient. This discussion involved patient education about the initial negative test results, his or her personalized 45-day risk for ACS, and a discussion about the potential need for observation and further cardiac testing. The discussion ended with the clinician and patient coming to a conjoined decision regarding which management option was most closely aligned with the patient's values and preferences.
Usual care. Clinicians treating patients in the UC arm did not have access to the quantitative pretest probability web tool or to the DA. Clinicians were instructed to have discussions regarding test results and treatment options per their usual practice. As the trial was intentionally pragmatic in design, UC was not standardized. 13 Data collection. Patient characteristics collected included age, sex, race, annual income, insurance status, highest level of education, health literacy, and numeracy. To collect data on race, we used the categories recommended by the Institute of Medicine (American Indian/Alaska Native, Asian, Black or African American, Native Hawaiian or other Pacific Islander, White/Caucasian, Other).
14 To assess health literacy, patients were asked 3 questions prior to the encounter with the clinician, each with a 5-point Likert response (Subjective Literacy Scale). 15 For the purposes of this study, the 3 items were summed into a total score after reverse coding 1 item: the higher the summed score, the lower the patients' subjective assessment of their general health literacy skills. To assess numeracy, which quantifies the ability to understand and use numbers in daily life, 16 patients were asked to respond to an 8-item questionnaire (Subjective Numeracy Scale). 17 Numeracy responses to all 8 questions were reversed and averaged, creating an overall score ranging from 1 to 6, where higher scores are indicative of lower levels of numeracy.
Outcomes. Data for the outcome measures assessed in this study were collected through recordings of the patient-provider interaction, a preencounter patient survey, a postencounter patient survey, and review of the electronic medical record (EMR). The patient surveys have been published with the study protocol. 9 The primary outcome for this study was patient knowledge regarding their risk for ACS and the available management options. This was prioritized by patient and caregiver representatives as the outcome of greatest importance and was assessed by immediate postvisit survey. Secondary outcomes that were also assessed by patient survey included the degree of patient uncertainty related to feeling uninformed regarding the management options measured using the Decisional Conflict Scale (DCS), 18 patient trust in their clinician measured using the Trust in Physician Scale (TPS), 19 and the clarity and helpfulness of the information shared and the acceptability of the DA reported on a 7-point Likert scale. Research team members reviewed encounter video recordings to assess the degree to which clinicians engaged patients in the decision-making process using the OPTION scale. 20 Finally, study coordinators reviewed the EMR to determine the patient disposition (admitted to the hospital, placed in the observation unit, discharged home), what testing the patient had (cardiac stress testing or coronary CT angiography), and whether the patient had an intervention performed (percutaneous coronary intervention or coronary artery bypass grafting).
Subgroups. We dichotomized each of the following variables to evaluate the differential effect of the DA across patient characteristics: age, sex, race, annual income, insurance status, level of education, health literacy, and numeracy. We chose to dichotomize for 2 reasons: 1) given the overall enrollment of 898 patients, more than 2 classifications would have resulted in many subgroups that were too small to analyze, and 2) binary classifications made the heterogeneity of effect simpler to analyze and interpret by way of interactions. 21 These classifications were based on both the distribution of the values, which we report in full, and conceptual considerations regarding the mostly likely contrasts to show heterogeneity of effect. Classifications were as follows: sex as ''female'' v. ''male,'' race as ''white'' v. ''nonwhite,'' annual income as ''less than $40,000'' v. ''greater than or equal to $40,000,'' insurance status as ''uninsured'' v. ''insured,'' education as ''less than or equal to high school/general education development (GED)'' v. ''greater than high school/GED,'' literacy as ''typical ( 3)'' v. ''low (.3),'' and numeracy as ''typical ( 4)'' v. ''low (.4).'' Patients missing a subgroup variable were excluded from the analysis for that subgroup. For race, the ''Other'' group was included with ''nonwhite.'' For education, the ''Other'' category was excluded from the dichotomous groups, as it could not be assumed to indicate either of the 2 categories. We also tested for interactions between each of these patient characteristics and trial outcomes with each variable classified as a continuous or ordinal variable, as appropriate for the data, and observed similar findings. For these reasons, we present the results of interaction testing between each dichotomized patient characteristic and trial outcomes.
Statistical Analysis
Sample size and power estimates for the trial have been reported elsewhere. 9 As with the primary analysis of the trial, 6 outcome assessments for this study were done using regression models (linear for continuous outcomes, multinomial for categorical outcomes) that included indicators for study arm assignment and study site. In addition, to assess the heterogeneity of DA effect across each of the subgroups, we included an interaction term for group assignment and subgroup. To improve interpretation, we also replicated the main trial analysis (i.e., with no interaction term) within each subgroup and reported the group effect and whether the effect differed significantly from zero. This group effect was reported as a coefficient for continuous outcomes and odds ratios for dichotomous or multinomial outcomes.
The statistical approach to subgroup analysis was informed by publication guidelines for reporting subgroup analyses. 21 Interaction testing between patient characteristics and the outcomes of patient knowledge, decisional conflict, involvement in decision making, and patient trust in physicians were prespecified, and a significance level of 5% was used to identify significant interactions for these subgroup effects. Given that a total of 80 comparisons were performed, we anticipated up to 0.05 3 80 or 4 significant interactions based on chance alone. As such, subgroup analyses that were not prespecified were considered hypothesis generating. All analyses were performed using Stata 14.1 (2016; StataCorp LP, College Station, TX).
Results
We enrolled 913 patients in the trial and, after 15 postrandomization exclusions, included 898 patients in the analysis. Details regarding the number of patients assessed for eligibility, enrolled, randomized, and the fidelity and completeness of follow-up data are reported elsewhere.
6 Table 1 summarizes patient and site characteristics. There were no significant differences in baseline characteristics between the 2 study arms. Each study site enrolled at least 10% of the overall population. Over half of the patients in each study arm were female, and over one-third in each arm were black. Income was relatively equally distributed, with approximately 20% in each arm having income in both the lowest category ($20,000 or less) and the highest category ($100,000 or more). About 30% had government insurance and less than 10% were uninsured, with the rest having private insurance. Close to one-third of patients in each study arm had the equivalent of a high school education or less. Over 60% of patients in each arm reported ''low'' health literacy, although less than half in each arm (38% UC, 42% DA) reported ''low'' numeracy.
Use of CPC increased knowledge, decreased decisional conflict, and increased patient engagement similarly across all patient subgroups (Table 2 ). There were, however, differences in effect between patient subgroups for the outcomes of knowledge (% questions correct) and trust in the physician. When comparing the DA effect across race subgroups, the DA appeared to increase knowledge more in the white compared with nonwhite subgroups (11.0% v. 4.8%, absolute difference [AD] = 6.2%, P for interaction test = 0.018). When comparing the effect across numeracy subgroups, the DA appeared to increase knowledge more in the ''typical'' subgroup than in the ''low'' subgroup (10.6% v. 4.7%, AD = 5.9%, P for interaction test = 0.025) (Figure 1) . Finally, when comparing the DA across health literacy subgroups, the DA increased patient trust in the physician more in patients with ''low'' health literacy than for those with ''normal'' health literacy (change in score of 3.7 v. -1.4; P for interaction test = 0.011) (Figure 2 ). There were no significant effect differences based on knowledge of ACS risk, decisional conflict, or patient involvement in the decision-making process (OPTION score). Numbers reported in each cell are coefficients, unless otherwise specified. P values are for an overall interaction between the decision aid and each characteristic. ACS, acute coronary syndrome.
b Indicates a significant decision aid effect for the subgroup compared with its control (usual care) for the outcome. Reported if the P value for the overall interaction is significant.
Regarding management decisions, there appeared to be differences in the decision to have a stress test across patient race groups (P = 0.004) and annual income (P = 0.028) (Suppl . Table S1 ). When assessing the effect of DA across subgroups, white patients and those with annual income $40,000 had a lower odds of having a stress test (0.48 with 95% confidence interval [CI] of 0.33-0.70 and 0.54 with 95% CI of 0.37-0.78, respectively; Figure 3 ). There were no significant interactions in the decision to have a CT angiogram or to undergo revascularization.
Discussion
Key Study Findings
In the prespecified analyses, the effect of the DA on patient knowledge, decisional conflict, and patient involvement in the decision was similar to the trial population in the elderly and in those with less formal education and less income. However, the DA increased knowledge to a greater degree in white patients and in patients with higher numeracy. Use of the DA in racial minorities did not significantly affect patient trust in physicians. In exploratory analyses, we observed greater patient trust in physicians with ''low'' literacy compared with those with ''typical'' literacy. We also observed a lower odds of cardiac stress testing in white patients compared with nonwhite patients and in those patients with an annual income of $40,000.
Meaning of the Study: Potential Implications for Clinicians and Researchers
Knowledge appeared to increase to a greater degree in patients with ''high'' numeracy compared with those with ''low'' numeracy. Given that communication of risk in numerical terms is frequently involved in SDM conversations, it is important for clinicians to follow best practices when communicating risk with patients such as use of natural frequencies, estimates of absolute risk, and a consistent denominator 22 and to anticipate that patients with low numeracy may have difficulty comprehending and applying numerical concepts to the decision. It is also important for SDM researchers to involve patients with limited numeracy in the DA development process and to test the effect of the DA in this subgroup of patients. We also observed greater increases in knowledge in white compared with nonwhite patients. Racial and ethnic differences between patients and physicians may affect knowledge transfer. However, we did not prespecify an interaction between patient race and knowledge, and this observation could be due to chance alone and should be interpreted with caution. We also did not observe that use of the DA increased patient trust in physicians to a greater degree in racial minority groups. We did, however, observe an interaction between ''low'' health literacy and patient trust in physicians. Although this interaction is interesting and supports the hypothesis that use of the DA increased patient trust in physicians to a greater degree in patients with low health literacy, this interaction was not prespecified and should be considered hypothesis generating only. Finally, white patients and patients with annual incomes of $40,000 appeared to be less likely to undergo stress testing than nonwhite patients and those with annual incomes of \$40,000. This is a potentially important finding, as SDM may decrease utilization when the knowledge of risk is effectively transferred, the patient understands the available management options, and there is ready access to outpatient follow-up. It is also possible that provider practice patterns primarily drove decision making in poor, nonwhite patients. While we anticipate that our initial testing was with a population containing a significant proportion of vulnerable patients, we did not specifically target vulnerable populations for tool development. Future work could consider oversampling from certain vulnerable populations for further tool refinement and testing.
Limitations and Strengths of the Study
The primary limitations of this study relate to issues of multiple testing and imprecision around estimates of subgroup effects. Given that a total of 80 comparisons were performed, one could estimate that up to 4 interactions (80 3 0.05) could be observed based on chance alone. To limit the risk of bias associated with multiple testing, we prespecified hypotheses based on prior observations in SDM trials 2 and prior literature demonstrating lower levels of patient trust in physicians in racial minority groups. 8 We also followed guideline recommendations for reporting subgroup analyses in clinical trials 21 by presenting only those subgroup analyses that were prespecified or based on a primary study outcome in the abstract, distinguishing subgroup analyses of special interest in the methods, basing analyses of the heterogeneity of DA effect on tests for interaction, and exercising caution in interpreting subgroup differences. Our analyses often yielded imprecise results of potentially important subgroup effects. However, this limitation is inherent in subgroup analyses of clinical trials, and to the best of the investigators' knowledge, the current investigation represents the largest cohort of patients enrolled in a SDM trial to date and has potential to reveal important insights related to the effect of a DA in potentially vulnerable patients.
Conclusions
Use of the CPC DA benefited all sociodemographic groups to a similar extent, with greater knowledge transfer in those self-reporting higher numeracy and greater patient trust in physicians among those with lower health literacy. These results indicate that a ''one-size-fits-all'' approach to implementing SDM interventions may be suboptimal. Tailoring development and implementation of the intervention to patient characteristics associated with the impact of the intervention may be necessary for optimal effectiveness.
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